Work

Views from Academia, Industry, Regulatory Agencies, and the Legal System

Year: 2021

Type: other

DOI: 10.1002/9781119701101.ch6

Authors: Joshua J. Gagne, Jerry Avorn, Nicolle M. Gatto, Jingping Mo, Gerald J. Dal Pan, June Raine, Shinobu Uzu, Aaron S. Kesselheim, Kerstin N. Vokinger

Institutions: Brigham and Women's Hospital, Johnson & Johnson (United States), Harvard University, Aetion (United States), Pfizer (United States), United States Food and Drug Administration, Center for Drug Evaluation and Research, Medicines and Healthcare products Regulatory Agency, Pharmaceuticals and Medical Devices Agency, University of Zurich

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4226441979

Cites: 54

Cited by:

Related to: 10